DD158738A5 - Verfahren zur herstellung von partikeln aus lipoidloeslichen stoffen - Google Patents
Verfahren zur herstellung von partikeln aus lipoidloeslichen stoffen Download PDFInfo
- Publication number
- DD158738A5 DD158738A5 DD81227326A DD22732681A DD158738A5 DD 158738 A5 DD158738 A5 DD 158738A5 DD 81227326 A DD81227326 A DD 81227326A DD 22732681 A DD22732681 A DD 22732681A DD 158738 A5 DD158738 A5 DD 158738A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- particles
- aqueous electrolyte
- electrolyte solution
- biologically active
- water
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/586—Liposomes, microcapsules or cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU79HU299A HU184141B (en) | 1979-12-27 | 1979-12-27 | Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DD158738A5 true DD158738A5 (de) | 1983-02-02 |
Family
ID=10997378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD81227326A DD158738A5 (de) | 1979-12-27 | 1981-01-30 | Verfahren zur herstellung von partikeln aus lipoidloeslichen stoffen |
Country Status (21)
Country | Link |
---|---|
US (1) | US4396630A (ru) |
JP (1) | JPS57112334A (ru) |
BE (1) | BE886884A (ru) |
CA (1) | CA1165237A (ru) |
CH (1) | CH655246A5 (ru) |
CS (1) | CS241478B2 (ru) |
DD (1) | DD158738A5 (ru) |
DE (1) | DE3048815A1 (ru) |
DK (1) | DK160288C (ru) |
ES (1) | ES8201316A1 (ru) |
FR (1) | FR2472386B1 (ru) |
GB (1) | GB2066203B (ru) |
HU (1) | HU184141B (ru) |
IT (1) | IT1150073B (ru) |
NL (1) | NL8007041A (ru) |
PL (1) | PL228755A1 (ru) |
PT (1) | PT72261B (ru) |
RO (1) | RO81371A (ru) |
SE (1) | SE453537B (ru) |
SU (1) | SU1487802A3 (ru) |
YU (1) | YU44413B (ru) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4598051A (en) * | 1980-03-12 | 1986-07-01 | The Regents Of The University Of California | Liposome conjugates and diagnostic methods therewith |
US4806466A (en) * | 1981-10-29 | 1989-02-21 | The Regents Of The University Of California | Cell agglutination reagent comprising conjugates of antibody covalently bound to liposomes |
FR2521565B1 (fr) * | 1982-02-17 | 1985-07-05 | Dior Sa Parfums Christian | Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees |
DD247570A3 (de) * | 1983-01-14 | 1987-07-15 | Univ Berlin Humboldt | Vesikulaeres trenn-, fuell- und traegermaterial |
US4515736A (en) * | 1983-05-12 | 1985-05-07 | The Regents Of The University Of California | Method for encapsulating materials into liposomes |
US5059591B1 (en) * | 1983-05-26 | 2000-04-25 | Liposome Co Inc | Drug preparations of reduced toxicity |
US4708861A (en) * | 1984-02-15 | 1987-11-24 | The Liposome Company, Inc. | Liposome-gel compositions |
US5916588A (en) * | 1984-04-12 | 1999-06-29 | The Liposome Company, Inc. | Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use |
US6090406A (en) * | 1984-04-12 | 2000-07-18 | The Liposome Company, Inc. | Potentiation of immune responses with liposomal adjuvants |
GB2160312B (en) * | 1984-04-13 | 1987-09-16 | South African Inventions | Adjuvant for immunisation |
PT78628B (en) * | 1984-05-02 | 1986-06-18 | Liposome Co Inc | Pharmaceutical composition with reduced toxicity |
US4619904A (en) * | 1984-10-29 | 1986-10-28 | General Electric Company | Agglutinating immunoassay using protein-coated liquid droplets |
US4857319A (en) * | 1985-01-11 | 1989-08-15 | The Regents Of The University Of California | Method for preserving liposomes |
EP0244405B1 (en) * | 1985-10-31 | 1991-10-23 | Kv Pharmaceutical Company | Vaginal delivery systems |
US5266329A (en) * | 1985-10-31 | 1993-11-30 | Kv Pharmaceutical Company | Vaginal delivery system |
US4790987A (en) * | 1985-11-15 | 1988-12-13 | Research Corporation | Viral glycoprotein subunit vaccine |
CA1338736C (fr) * | 1986-12-05 | 1996-11-26 | Roger Baurain | Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation |
US4748024A (en) * | 1987-04-06 | 1988-05-31 | Endocon, Inc. | Flash flow fused medicinal implants |
US5688519A (en) * | 1987-04-06 | 1997-11-18 | Leonard; Robert J. | Flash-flow fused medicinal implants |
WO1990001948A1 (en) * | 1988-08-25 | 1990-03-08 | The Liposome Company, Inc. | Influenza vaccine and novel adjuvants |
EP0374296B1 (en) * | 1988-12-22 | 1995-02-01 | Dade International Inc. | Lipohaptens and use of carrier-bound lipohaptens in immunoassays |
US5100662A (en) * | 1989-08-23 | 1992-03-31 | The Liposome Company, Inc. | Steroidal liposomes exhibiting enhanced stability |
JPH07113641B2 (ja) * | 1989-11-17 | 1995-12-06 | 積水化学工業株式会社 | 梅毒診断試薬の製造方法 |
NL9000207A (ru) * | 1990-01-29 | 1991-08-16 | Duphar Int Res | |
HU220136B (hu) * | 1990-06-29 | 2001-11-28 | Chiron Corp. | Eljárás liposzómákat tartalmazó vakcinakészítmény előállítására |
US5709879A (en) * | 1990-06-29 | 1998-01-20 | Chiron Corporation | Vaccine compositions containing liposomes |
IE912535A1 (en) * | 1990-07-27 | 1992-01-29 | Res Dev Foundation | Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens |
WO1992004887A1 (en) * | 1990-09-25 | 1992-04-02 | Kyowa Hakko Kogyo Co., Ltd. | Induction of cytotoxic t cell |
US6048531A (en) * | 1991-04-15 | 2000-04-11 | Albany Medical College | Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies |
US5336507A (en) * | 1992-12-11 | 1994-08-09 | Sterling Winthrop Inc. | Use of charged phospholipids to reduce nanoparticle aggregation |
GB9320668D0 (en) * | 1993-10-07 | 1993-11-24 | Secr Defence | Liposomes containing particulare materials |
AUPM500494A0 (en) * | 1994-04-12 | 1994-05-05 | Minister For Agriculture & Rural Affairs For The State Of New South Wales, The | Composition for use in increasing mucosal immunity |
ATE413164T1 (de) * | 2000-11-09 | 2008-11-15 | Neopharm Inc | Sn-38-lipidkomplexe und verfahren zu ihrer verwendung |
WO2003030864A1 (en) * | 2001-05-29 | 2003-04-17 | Neopharm, Inc. | Liposomal formulation of irinotecan |
JP2005530704A (ja) * | 2002-03-05 | 2005-10-13 | トランセイブ, インク. | 細胞内感染を予防及び治療するための吸入システム |
US20060030578A1 (en) * | 2002-08-20 | 2006-02-09 | Neopharm, Inc. | Pharmaceutically active lipid based formulation of irinotecan |
AU2003296897A1 (en) * | 2002-08-20 | 2004-05-04 | Neopharm, Inc. | Pharmaceutical formulations of camptothecine derivatives |
US7718189B2 (en) * | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
CN1747738B (zh) * | 2002-10-29 | 2010-11-24 | 川塞夫有限公司 | 缓释抗感染剂 |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
KR100651728B1 (ko) * | 2004-11-10 | 2006-12-06 | 한국전자통신연구원 | 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법 |
WO2006090816A1 (ja) * | 2005-02-25 | 2006-08-31 | Mie University | リポソームワクチンの作製法 |
US8226975B2 (en) | 2005-12-08 | 2012-07-24 | Insmed Incorporated | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
WO2008137717A1 (en) | 2007-05-04 | 2008-11-13 | Transave, Inc. | Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
EP4005576B1 (en) | 2012-05-21 | 2023-12-13 | Insmed Incorporated | Systems for treating pulmonary infections |
AU2013352259B2 (en) | 2012-11-29 | 2018-06-14 | Insmed Incorporated | Stabilized vancomycin formulations |
US9895385B2 (en) | 2014-05-15 | 2018-02-20 | Insmed Incorporated | Methods for treating pulmonary non-tuberculous mycobacterial infections |
JP7460534B2 (ja) | 2018-03-30 | 2024-04-02 | インスメッド インコーポレイテッド | リポソーム医薬品の連続製造方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3265629A (en) * | 1958-12-22 | 1966-08-09 | Ncr Co | Coating by phase separation |
DE2249552A1 (de) * | 1971-10-12 | 1973-05-30 | Inchema S A | Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen |
GB1502774A (en) * | 1974-06-25 | 1978-03-01 | Nat Res Dev | Immunological preparations |
JPS5126213A (ja) * | 1974-08-21 | 1976-03-04 | Tanabe Seiyaku Co | Johoseibiryushiseizaino seiho |
GB1564500A (en) * | 1975-09-29 | 1980-04-10 | Wellcome Found | Biological preparations |
GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
GB1575343A (en) * | 1977-05-10 | 1980-09-17 | Ici Ltd | Method for preparing liposome compositions containing biologically active compounds |
IT1110989B (it) * | 1979-01-19 | 1986-01-13 | Erba Farmitalia | Forme farmaceutiche costitutite da liposomi e procedimenti relativi |
FR2416008A1 (fr) * | 1978-02-02 | 1979-08-31 | Oreal | Lyophilisats de liposomes |
US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
JPS55118415A (en) * | 1979-02-28 | 1980-09-11 | Pii Papahadojiyopo Dometoriosu | Method of encapsulating biologically active substance in lipoid cell |
-
1979
- 1979-12-27 HU HU79HU299A patent/HU184141B/hu unknown
-
1980
- 1980-12-12 CH CH9166/80A patent/CH655246A5/de not_active IP Right Cessation
- 1980-12-19 US US06/218,126 patent/US4396630A/en not_active Expired - Fee Related
- 1980-12-22 PT PT72261A patent/PT72261B/pt unknown
- 1980-12-22 ES ES80498048A patent/ES8201316A1/es not_active Expired
- 1980-12-22 SE SE8009068A patent/SE453537B/sv not_active IP Right Cessation
- 1980-12-23 DK DK552280A patent/DK160288C/da active
- 1980-12-23 CS CS809246A patent/CS241478B2/cs unknown
- 1980-12-23 DE DE19803048815 patent/DE3048815A1/de active Granted
- 1980-12-23 GB GB804281A patent/GB2066203B/en not_active Expired
- 1980-12-23 PL PL22875580A patent/PL228755A1/xx unknown
- 1980-12-24 NL NL8007041A patent/NL8007041A/nl not_active Application Discontinuation
- 1980-12-24 IT IT26950/80A patent/IT1150073B/it active
- 1980-12-24 CA CA000367565A patent/CA1165237A/en not_active Expired
- 1980-12-24 FR FR8027496A patent/FR2472386B1/fr not_active Expired
- 1980-12-25 RO RO80102952A patent/RO81371A/ro unknown
- 1980-12-26 JP JP55184157A patent/JPS57112334A/ja active Granted
- 1980-12-26 YU YU3290/80A patent/YU44413B/xx unknown
- 1980-12-26 SU SU803220898A patent/SU1487802A3/ru active
- 1980-12-29 BE BE0/203337A patent/BE886884A/fr not_active IP Right Cessation
-
1981
- 1981-01-30 DD DD81227326A patent/DD158738A5/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NL8007041A (nl) | 1981-07-16 |
ES498048A0 (es) | 1981-12-16 |
SU1487802A3 (ru) | 1989-06-15 |
IT8026950A0 (it) | 1980-12-24 |
SE453537B (sv) | 1988-02-08 |
JPH0314814B2 (ru) | 1991-02-27 |
DK160288C (da) | 1991-08-05 |
IT1150073B (it) | 1986-12-10 |
CH655246A5 (de) | 1986-04-15 |
YU329080A (en) | 1984-04-30 |
FR2472386B1 (ru) | 1985-08-23 |
GB2066203A (en) | 1981-07-08 |
CA1165237A (en) | 1984-04-10 |
CS241478B2 (en) | 1986-03-13 |
PT72261B (en) | 1981-11-05 |
BE886884A (fr) | 1981-06-29 |
US4396630A (en) | 1983-08-02 |
DK552280A (da) | 1981-06-28 |
GB2066203B (en) | 1984-01-11 |
RO81371A (ro) | 1984-04-02 |
HU184141B (en) | 1984-07-30 |
ES8201316A1 (es) | 1981-12-16 |
YU44413B (en) | 1990-08-31 |
FR2472386A1 (ru) | 1981-07-03 |
JPS57112334A (en) | 1982-07-13 |
SE8009068L (sv) | 1981-06-28 |
CS924680A2 (en) | 1985-07-16 |
PL228755A1 (ru) | 1982-02-15 |
RO81371B (ro) | 1983-11-02 |
DK160288B (da) | 1991-02-25 |
PT72261A (en) | 1981-01-01 |
DE3048815A1 (de) | 1981-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DD158738A5 (de) | Verfahren zur herstellung von partikeln aus lipoidloeslichen stoffen | |
DE69413024T2 (de) | Verfahren zur herstellung von immunogenen oder diagnostischen reagentien und ebensolche | |
DE69408527T2 (de) | Makromolekulare mikropartikel und verfahren zu ihrer herstellung | |
DE109942T1 (de) | Immunogener protein- oder peptidkomplex, verfahren zur herstellung dieses komplexes und seine verwendung als immunstimulans und als impfstoff. | |
DE2638762A1 (de) | Wasserloesliche adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
DE2603321A1 (de) | Emulsion auf der grundlage eines stoffwechselfaehigen pflanzlichen oels und wasser | |
DE68922109T2 (de) | Gamma-inulin-zusammensetzungen. | |
DE69633233T2 (de) | Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus | |
CH652032A5 (de) | Verfahren zur herstellung von immunbiologischen praeparaten, die fuer den nachweis, das vorbeugen und/oder die behandlung der candida guilliermondii-infektion geeignet sind. | |
CH634923A5 (en) | Process for the preparation of pili from Neisseria gonorrhoeae | |
DE1492243C3 (de) | Injizierbare Impfstoffe | |
DE2262427A1 (de) | Immunostimulierendes mittel und verfahren zu dessen herstellung | |
DE2728802C2 (de) | Verfahren zum Herstellen eines antischistosomen immunologischen Mittels | |
DE1265916B (de) | Verfahren zur Herstellung eines Brucellose-Impfstoffs | |
DE1617674A1 (de) | Verfahren zur Herstellung eines lange wirksamen Impfstoffes | |
CH639667A5 (de) | Verfahren zur herstellung von peptidkomplexen aus dns-haltigen organismen. | |
EP0034301A2 (de) | Verfahren zur Bestimmung von Immunkomplexen | |
DE3112334A1 (de) | "kuenstliche kontroll- und standardseren, verfahren zu ihrer herstellung und ihre verwendung" | |
DE2644149C3 (de) | Neue Parasiten-Antigene | |
DE2141901B2 (de) | Steriler Impfstoff, der abgetötete Organismen des genus Fusiformis nodosus enthält | |
DE1792298A1 (de) | Immunochromatographische Verteilung von loeslichen Antigenen | |
CH526631A (de) | Mittel zur Herstellung eines immunologischen Indikators, Verfahren zu dessen Herstellung und dessen Verwendung | |
DE2626350A1 (de) | Antigene mittel | |
Peters | Ultra-Microscopic Examination of the Blood-Serum in Disease | |
Aitken et al. | Experimental intraperitoneal Salmonella dublin infection in rats: effects of concurrent infections with Fasciola hepatica and Nippostrongylus brasiliensis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |